Balsalazide Disodium Hydrate is a prodrug that delivers 5-aminosalicylic acid to the colon via bacterial azo-bond cleavage, used for the induction and maintenance of remission in ulcerative colitis. Simson Pharma's Balsalazide reference standard and impurities support compendial testing for this colon-targeted gastroenterology therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Balsalazide Disodium Hydrate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.